BiomedicalPublications

Molecular Neurodegeneration

BioMed Central·United Kingdom·ISSN 1750-1326

Open accessIn DOAJFee waivers availableMedicine

Cost to publish

$3,090

Open-access article processing charge, list price.

Time to publication

12 wks

Broadly typical for the field.

h-index

168

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

17.7

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Molecular Neurodegeneration is listed at $3,090. The publisher also lists 2,890 EUR, 2,490 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Molecular Neurodegeneration, as recorded by OpenAlex for each year. The fee has risen 20% since 2019, from $2,580 to $3,090.

$0$1.5k$3.1k2019: $2,58020192020: $2,58020202021: $2,79020212022: $2,89020222023: $2,99020232024: $2,99020242025: $3,0902025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC0
Author keeps copyrightYes
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Molecular Neurodegeneration publishes most, derived from the topics assigned to its indexed articles.

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchGenetic Neurodegenerative DiseasesNeurogenesis and neuroplasticity mechanismsNuclear Receptors and SignalingNeuroscience and Neuropharmacology ResearchCholinesterase and Neurodegenerative Diseases

Publication record

Indexed articles1,589
Total citations120,764
i10-index1,206
Most recent indexed article2026
Open access since2006
All ISSNs1750-1326

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.